Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Tretinoin and Interleukin-10

supplement:

Tretinoin

Research Papers that Mention the Interaction

Additionally, ATRA reduces the expression of immunosuppressive genes including PD‐L1, IL‐10 , and indoleamine 2,3‐dioxygenase by MDSCs.
International immunopharmacology  •  2018  |  View Paper
ATRA therapy could significantly increase the percentage of Treg cell, IL-10 level and Foxp3 expression.
Thrombosis research  •  2016  |  View Paper
ATRA treatment not only reduced pro-inflammatory cytokine responses, such as TNF-α, IL-6, IL-1β, IFN-γ and IL-17 production but also increased IL-10 response in the supernatant of intestinal tissue.
Immunobiology  •  2016  |  View Paper
We show that ATRA alleviates the negative feedback loop effect of IL-10 anti-inflammatory cytokine on NLRP3 inflammasome function by inhibiting the Akt-mTOR-STAT3 signaling axis.
Cells  •  2020  |  View Paper
ATRA stimulates megakaryocytopoiesis, restores concentration of regulatory T cells, and increases interleukin-10 concentrations and FOXP3 (forkhead box protein P3) expression.
The Lancet. Haematology  •  2017  |  View Paper
Importantly, RA enhanced the secretion of IL-10 by MS-derived B cells without affecting the levels of the pro-inflammatory cytokine TNF-α.
Journal of Neuroimmunology  •  2015  |  View Paper
While atRA downregulated the proinflammatory cytokines, e.g., IL-12 and TNF-α, the production of an immune modulating cytokine, IL-10 was enhanced by atRA.
Journal of Clinical Immunology  •  2006  |  View Paper
In addition, IL-10 abolishes all trans retinoic acid (ATRA)-induced growth inhibition of myeloma cells.
Leukemia & lymphoma  •  2002  |  View Paper
RA differentially modulated the expression of interleukin‐1β ( IL‐10 ), IL‐6, and IL‐8 mRNAs depending on the inducing stimulus.
Journal of leukocyte biology  •  1993  |  View Paper
Our data demonstrate that RA treatment enhances TLR2-dependent IL-10 production from T cells and this, in turn, potentiates T regulatory cell (TREG) generation without the need for activation of antigen presenting cells.
PloS one  •  2015  |  View Paper
Show More